Gastrointestinal Cancer

SH 01 - Science Highlights 01 - Gastrointestinal (GI)

9/16/2019
8:00 AM - 8:30 AM
Location: Room W181

Session Type: Science Highlights
0.50 AMA PRA Category 1 Credits™
0.50 CAMPEP Credits

This session will review the most impactful abstracts from the GI track

* Multicenter Phase II Study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma = 28954 - Multicenter Phase II Study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma = 5 cm (KROG 12-02)
* The genomic landscape of anal cancer and its relationship to clinical outcomes: an exploratory analysis of NRG Oncology/RTOG 98-11
* Improved Stratification for Risk of Early Metastases by Baseline Circulating Tumor Cell Counts for Locally Advanced Rectal Cancer in Neoadjuvant Setting: an Exploratory Analysis from a Phase III trial
* ctDNA as a potential prognostic marker for locally advanced rectal cancer patients receiving neoadjuvant chemo-radiation therapy on disease-free survival (DFS)
* Patient-derived Organoids (PDO) as the potential model to Predict Treatment Outcome of Rectal Cancer Patients Underwent Neo-adjuvant Chemoradiotherapy

Presentations:


Assets

SH 01 - Science Highlights 01 - Gastrointestinal (GI)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SH 01 - Science Highlights 01 - Gastrointestinal (GI)